Trial of IV Injection of CV787 in Hormone Refractory Metastatic Prostate Cancer
NCT00116155 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL
Last updated 2005-06-28
Summary
This is a multi-center, open-label, dose finding study of CV787 adenovirus in patients with hormone refractory metastatic prostate cancer. Patients will receive treatment intravenously at one of up to nine dose levels, each containing three to six patients.
Conditions
Interventions
- BIOLOGICAL
-
CV787 (CG7870)
Sponsors & Collaborators
-
Cell Genesys
lead INDUSTRY
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- Healthy Volunteers
- No
Timeline & Regulatory
More Related Trials
-
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy
NCT00473512 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer
NCT01817738 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer
NCT02458716 ·Status: COMPLETED ·Phase: PHASE1
-
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
NCT03678025 ·Status: RECRUITING ·Phase: PHASE3
-
Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer
NCT00583024 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study Evaluating Chemotherapy in Prostate Cancer
NCT01978873 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
NCT01283373 ·Status: COMPLETED ·Phase: PHASE1
-
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
NCT04787744 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer
NCT03431350 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06145633 ·Status: RECRUITING ·Phase: PHASE2
-
Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00005847 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Immunotherapy in Biochemically Recurrent Prostate Cancer
NCT03315871 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer
NCT03358563 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer
NCT01322490 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease
NCT00831467 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
NCT00099086 ·Status: COMPLETED ·Phase: PHASE1
-
Once-daily Oral Seviteronel in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone.
NCT02445976 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer
NCT00108290 ·Status: COMPLETED ·Phase: PHASE2
-
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
NCT00771017 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers
NCT02655822 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
NCT07287150 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer
NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapy
NCT02217566 ·Status: COMPLETED ·Phase: PHASE2
-
Dual mTOR Inhibitor MLN0128 in Advanced Castration-Resistant Prostate Cancer (CRPC) Patients
NCT02091531 ·Status: COMPLETED ·Phase: PHASE2
-
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer
NCT00589472 ·Status: COMPLETED ·Phase: PHASE2